A
$ Value
$0
Shares
17,500
Price
$0
Filed
Aug 14
Insider
Name
Blaustein Robert
Title
Chief Development Officer
CIK
0002053149
Roles
Officer
Transaction Details
Transaction Date
2025-08-12
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
17,500
Footnotes
Restricted Stock Units ("RSUs") granted to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in four equal annual installments beginning on August 12, 2026. | 1/48th of the shares subject to the option vest each month beginning on September 12, 2025, subject to the Reporting Person continuing as a service provider through each vest date.
Filing Info
Other Insiders at EWTX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Donovan Joanne M.
CMO
|
— | $2.1M | 2026-04-01 |
| Fox Jonathan C | — | — | 2026-04-01 |